ACH
ACH
Positions held
Your positionsACH isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-06 · New Strong Sell Stocks for October 6th
2026-08-17 · Accendra Health drops equity issuance plan as CEO succession process advances
2026-08-17 · Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans
2026-08-14 · UBS Adjusts Price Target on Acadia Healthcare to $1.50 From $4.50, Keeps Neutral Rating
2026-08-13 · UBS Adjusts Price Target on Accendra Health to $1.50 From $4.50, Keeps Neutral Rating
2026-08-10 · Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value
2026-08-10 · Accendra Health Chief Executive Edward Pesicka to Retire
2026-08-10 · Accendra Health Reports Second Quarter 2026 Financial Results
2026-08-10 · Accendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search
2026-08-06 · ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates
2026-07-27 · Accendra Health Announces Leadership Appointments in IT and Procurement
Price (daily)
Full chart · RSI · MACD · patterns